Genetic Testing and Tailored Treatment for Thyroid Disorders: Molecular Basis and New Trends
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Endocrinology and Metabolism".
Deadline for manuscript submissions: 31 August 2024 | Viewed by 102
Special Issue Editor
Interests: breast cancer; thyroid cancer; endocrine neoplasm; parathyroid gland; adrenal tumour
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Thyroid diseases are a group of common endocrine disorders with diverse clinical presentations and significant health consequences. Recent advances in genetic research have unveiled the complex genetic architecture of thyroid diseases, offering new insights into disease pathogenesis and opening new avenues for personalized medicine. This Special Issue focuses on the latest developments in the genetic basis and emerging therapeutic approaches for thyroid diseases.
Key topics:
- Genetic epidemiology: in-depth analysis of genetic variants and risk factors associated with various thyroid diseases, including thyroid cancer, Graves’ disease, hypothyroidism, and Hashimoto’s thyroiditis;
- Functional genomics: elucidation of the molecular mechanisms underlying thyroid disease-associated genetic variants, including their impact on gene expression, protein function, and cellular signaling pathways;
- Personalized medicine: development and implementation of individualized treatment strategies based on genetic information, including targeted therapies, gene therapy, and precision medicine;
- Novel therapeutic targets: identification and validation of novel therapeutic targets for thyroid diseases, with a focus on druggable genes and pathways.
This Special Issue seeks to offer a thorough understanding of the current state of knowledge in the field of thyroid disease genetics and encourage additional research in this rapidly advancing field. The effective integration of genetic knowledge with clinical practice has the potential to enhance the diagnosis, prognosis, and treatment of thyroid disorders, thereby resulting in improved patient outcomes. Since IJMS is a journal of molecular science, pure clinical studies or sociological research will not be suitable for our journal. However, clinical submissions with biomolecular experiments are welcomed.
Dr. Kyoung Sik Park
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- thyroid diseases
- genetics
- personalized medicine
- novel therapies
